Intranasal administration of ACTH(1-24) stimulates catecholamine secretion

Hormone and Metabolic Research

Volumn 37, Issue 8, 2005, Pages 489-493

  Yoshida Hiroi, M ^a   Tsuchida, Y ^a   Yoshino, C ^a   Hiroi, Naoki ^a,b,c  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Saiseikai Kanagawa ken Hospital   (Japan)

^c Saiseikai Kanagawa ken Hospital   (Japan)

Author keywords

Adrenocorticotropic hormone; Catecholamine; Cortisol; Epinephrine; Norepinephrine

Indexed keywords

ADRENALIN; ALDOSTERONE; DOPAMINE; HYDROCORTISONE; NORADRENALIN; TETRACOSACTIDE;

ADRENAL MEDULLA; ADRENALIN BLOOD LEVEL; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DRUG ABSORPTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADMINISTRATION, INTRANASAL; ADULT; CATECHOLAMINES; COSYNTROPIN; HORMONES; HUMANS; INJECTIONS, INTRAVENOUS; MALE;

EID: 24944584484     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870307     Document Type: Article

References (31)

1. Axelrod J. Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. Pharmacol Rev 1966; 18: 95-113
2. Hiroi N, Ichijo T, Ueshiba H, Miyachi Y. Intranasal administration of adrenocorticotropin-(1-24) stimulates adrenocortical hormone secretion. J Clin Endocrinol Metab 2002; 87: 1750-1753
3. Yoshida-Hiroi M, Bradbury MJ, Eisenhofer G, Hiroi N, Vale WW, Novotny GE, Hartwig HG, Scherbaum WA, Bornstein SR. Chromaffin cell function and structure is impaired in corticotropin-releasing hormone receptor type 1-null mice. Mol Psychiatry 2002; 7: 967-974
4. Nohta H, Lee MK, Ohkura Y. Fluorescence products of the reaction for the determination of catecholamines with 1,2-diarylethylenediamines. Analytica Chimica Acta 1992; 267: 137-139
5. Rudman D, Moffitt SD, Fernhoff PM, Blackston RD, Faraj BA. Epinephrine deficiency in hypocorticotropic hypopituitary children. J Clin Endocrinol Metab 1981; 53: 722-729
6. Bornstein SR, Tajima T, Eisenhofer G, Haidan A, Aguilera G. Adrenomedullary function is severely impaired in 21-hydroxylase-deficient mice. FASEB J 1999; 13: 1185-1194
7. Merke DP, Chrousos GP, Eisenhofer G, Weise M, Keil MF, Rogol AD, Van Wyk JJ, Bornstein SR. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med 2000; 343: 1362-1368
8. Wurtman RJ. Control of epinephrine synthesis by the pituitary and adrenal cortex: possible role in the pathophysiology of chronic stress. Recent Adv Biol Psychiatry 1966; 9: 359-368
9. Axelrod J, Reisine TD. Stress hormones: their interaction and regulation. Science 1984; 224: 452-459
10. Doupe AJ, Landis SC, Patterson PH. Environmental influences in the development of neural crest derivatives: glucocorticoids, growth factors, and chromaffin cell plasticity. J Neurosci 1985; 5: 2119-2142
11. Wurtman RJ, Axelrod J. Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids. J Biol Chem 1966; 241: 2301-2305
12. Ray PP, Chaudhuri-Sengupta S, Maiti BR. Adrenomedullary and glycemic responses to ACTH, corticosterone, aldosterone, epinephrine and norepinephrine administrations in the soft-shelled turtle. Folia Biol (Krakow) 2004; 52: 73-80
13. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. The cloning of a family of genes that encode the melanocortin receptors. Science 1992; 257: 1248-1251
14. Liakos P, Chambaz EM, Feige JJ, Defaye G. Expression and regulation of melanocortin receptor-5 (MC5-R) in the bovine adrenal cortex. Mol Cell Endocrinol 2000; 159: 99-107
15. Bornstein SR, Ehrhart-Bornstein M, Usadel H, Bockmann M, Scherbaum WA. Morphological evidence for a close interaction of chromaffin cells with cortical cells within the adrenal gland. Cell Tissue Res 1991; 265: 1-9
16. Bornstein SR, Gonzalez-Hernandez JA, Ehrhart-Bornstein M, Adler G, Scherbaum WA. Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab 1994; 78: 225-232
17. Bornstein SR, Ehrhart-Bornstein M. Ultrastructural evidence for a paracrine regulation of the rat adrenal cortex mediated by the local release of catecholamines from chromaffin cells. Endocrinology 1992; 131: 3126-3168
18. Hansen IL, Levy MM, Kerr DS. Differential diagnosis of hypoglycemia in children by responses to fasting and 2-deoxyglucose. Metabolism 1983; 32: 960-970
19. Sizonenko PC, Paunier L, Vallotton B, Cuendet GS, Zahnd G, Marliss EB. Response to 2-deoxy-D-glucose and to glucagon in "ketotic hypoglycemia" of childhood: evidence for epinephrine deficiency and altered alanine availability. Pediatr Res 1973; 7: 983-993
20. Kjaer M. Regulation of hormonal and metabolic responses during exercise in humans. Exerc Sport Sci Rev 1992; 20: 161-184
21. Johnson MD, Grignolo A, Kuhn CM, Schanberg SM. Hypertension and cardiovascular hypertrophy during chronic catecholamine infusion in rats. Life Sci 1983; 33: 169-180
22. Sutanen P. Stress, coronary disease, and coronary death. Ann Clin Res 1987; 19: 96-103
23. Hauss WH, Bauch HJ, Schulte H. Adrenaline and noradrenaline as possible chemical mediators in the pathogenesis of arteriosclerosis. Ann N Y Acad Sci 1990; 598: 91-101
24. Southwick SM, Paige S, Morgan CA 3rd, Bremner JD, Krystal JH, Charney DS. Neurotransmitter alterations in PTSD: catecholamines and serotonin. Semin Clin Neuropsychiatry 1999; 4: 242-248
25. Swerdlow AJ, Higgins CD, Brook CG, Dunger DB, Hindmarsh PC, Price DA, Savage MO. Mortality in patients with congenital adrenal hyperplasia: a cohort study. J Pediatr 1998; 133: 516-520
26. Hinde FR, Johnston DI. Hypoglycaemia during illness in children with congenital adrenal hyperplasia. Br Med J (Clin Res Ed) 1984; 289: 1603-1604
27. Weise M, Mehlinger SL, Drinkard B, Rawson E, Charmandari E, Hiroi M, Eisenhofer G, Yanovski JA, Chrousos GP, Merke DP. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise. J Clin Endocrinol Metab 2004; 89: 591-597
28. Lalej-Bennis D, Boillot J, Bardin C, Zirinis P, Coste A, Escudier E, Chast F, Peynegre R, Slama G, Selam JL. Six month administration of gelified intranasal insulin in 16 type 1 diabetic patients under multiple injections: efficacy vs subcutaneous injections and local tolerance. Diabetes Metab 2001; 27: 372-377
29. Wilson AM, Sims EJ, Lipworth BJ. Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment. Clin Endocrinol (Oxf) 1999; 50: 329-335
30. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med 1999; 159: 941-955
31. Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. Ann Allergy Asthma Immunol 2001; 87: 379-385